Nov 13, 2025 04:15PM
Aug 14, 2025 07:39AM
Aug 13, 2025 04:05PM
Jul 14, 2025 04:05PM
Jul 14, 2025 04:05PM
Jun 10, 2025 06:08AM
May 21, 2025 09:11AM Alumis (ALMS) Completes Merger with ACELYRIN
May 21, 2025 09:10AM
May 14, 2025 04:05PM
May 13, 2025 01:00PM
May 13, 2025 01:00PM
May 13, 2025 01:00PM
May 13, 2025 01:00PM
May 6, 2025 04:30PM Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
May 1, 2025 01:31PM
May 1, 2025 01:30PM
Apr 22, 2025 06:59AM
Apr 21, 2025 06:36AM
Apr 21, 2025 06:30AM
Apr 4, 2025 04:36PM
Apr 4, 2025 04:34PM Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
Mar 20, 2025 08:06AM
Mar 19, 2025 04:05PM
Mar 4, 2025 09:05AM
Mar 4, 2025 09:01AM
Mar 4, 2025 09:01AM
Mar 4, 2025 09:00AM
Feb 21, 2025 07:21AM Acelyrin (SLRN) Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences
Feb 20, 2025 09:00PM
Feb 7, 2025 06:48AM
Feb 6, 2025 04:16PM
Feb 6, 2025 04:15PM
Jan 28, 2025 08:05AM
Jan 28, 2025 08:00AM
Nov 13, 2024 04:05PM Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All